Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.
Goodkin, D E
Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. [electronic resource] - Annals of neurology Jan 1995 - 30-40 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0364-5134
10.1002/ana.410370108 doi
Administration, Oral
Adult
Chronic Disease
Double-Blind Method
Female
Humans
Immunosuppression Therapy
Male
Methotrexate--administration & dosage
Middle Aged
Multiple Sclerosis--drug therapy
Treatment Failure
Treatment Outcome
Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. [electronic resource] - Annals of neurology Jan 1995 - 30-40 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0364-5134
10.1002/ana.410370108 doi
Administration, Oral
Adult
Chronic Disease
Double-Blind Method
Female
Humans
Immunosuppression Therapy
Male
Methotrexate--administration & dosage
Middle Aged
Multiple Sclerosis--drug therapy
Treatment Failure
Treatment Outcome